Grandfield & Dodd’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
Other funds holding PDSB
Grandfield & Dodd's PDSB Position: Q3 2026 in Review
Grandfield & Dodd held its PDS Biotechnology (PDSB) position steady in Q3 2026 at 10,000 shares worth $7.51K. The position accounts for ﹤0.01% of the portfolio, ranked #216.
Grandfield & Dodd first reported a position in PDSB in Q2 2025 and has held it in 6 quarters since. The position peaked at $13.3K in Q2 2025. 60 funds tracked by Wall St. Rank hold PDSB as of Q3 2026.
- Grandfield & Dodd held 10,000 shares of PDS Biotechnology worth $7.51K as of Q3 2026.
- Grandfield & Dodd left its PDS Biotechnology share count unchanged in Q3 2026.
- PDS Biotechnology made up ﹤0.01% of Grandfield & Dodd's portfolio in Q3 2026, its #216 holding.
- Grandfield & Dodd first reported a position in PDS Biotechnology in Q2 2025 and has held it in 6 quarters since.
- Grandfield & Dodd's PDS Biotechnology position peaked at $13.3K in Q2 2025.
- 60 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2026.
Based on Grandfield & Dodd's 13F filing for Q3 2026, filed 29 Oct 2026.